“Be fearful when others are greedy, and be greedy when others are fearful.” – Warren Buffett
As China and the rest of Asia ring in the “Lunar New Year”, products which may be hot sellers in the pharmacies are those provided by China Sky One Medical, Inc. (Nasdaq: CSKI).
With a distribution network covers 22 provinces and 125 municipalities in the PRC as well as various wash fluids, tablets, liniments, syrups, capsules, granules, injections, aerosols, and oral liquids, China Sky One Medical distributes the following of its products to Chinese domestic pharmaceutical chains:
- Camphor cream to treat treatment of various pathogens on the skin surface, such as mycete, trichopytic, staphylococcal bacteria aureus, bacillus coli, and candida albicans;
- Hemorrhoids ointment, which is made in soft ointment form and is effective in sterilizing and relieving hemorrhoid symptoms, including itching, distending pain, burning, and bleeding;
- Sumei slim patch, a natural treatment for weight loss; and pain relief patch used for various ailments, including fever, headache, heart dysentery, diarrhea, and stiffness and pain caused by hypertension.
- An anti-hypertension patch that stimulates blood capillaries, improves circulation, and reduces blood pressure;
- QiXue asthma patch, which is designed for the treatment of chronic inflammation of the airways and lungs;
- Stomatitis spray used for the treatment of dental ulcers, pharyngitis, and faucitis;
- Naphazoline Hydrochloride eye drops for the temporary relief of eye redness associated with minor irritations;
- A cardiac arrest early examination kit used for early stage diagnosis of myocardial infarction;
- Naftopidil dispersible tablet designed to treat benign enlargement of the prostate among middle age males
With a market that comprises nearly 20% of the world’s population, China Sky One Medical is one of the rare companies to be screened which have a positive P/E ratio, healthy average trading volume and share value under $2. Having had a few bouts of director’s sick and resigning in late December, China Sky One Medical has seen its stock price celebrated gaining nearly 30% since January 18th.
Based in Harbin, China, Chine Sky One Medical’ stock is traded under the symbol CSKI on the NASDAQ Stock Exchange and has 297 listed full time employees.
Website: www.cski.com.cn/english/
Company Snapshot:
| Trading Symbol: | NASDAQ: CSKI |
| Last Price: | $1.48 (After Hours) |
| Avg Vol (3 month): | 65,198 |
| Avg Vol (10 day): | 117,086 |
| Market Cap: | 25.24M |
| EBITDA (ttm)6: | 26.67M |
| Total Cash (mrq): | $21.35M |
| Shares Outstanding: | 16.94 million shares |
| Shares Short (12/30/11): | 875.51 thousand shares |
| Shares Held by Insiders: | 36.76% |
| Institutions Holding Shares: | 19 |
| Top Institutional Holder: | 1,163,422 shares Pope Asset Management, LLC (as of 9/30/2011) |
| Top Mutual Fund Holder: | 11,600 shares Schroder Global SER TR-North American Equity Fund (as of 10/31/2011) |
| Contact Information: | No 2158 North Xiang An Road Song Bei District Harbin, 150028 China |
| Investor/Analyst inquiries: | Mr. Crocker Coulson President CCG Investor Relations Tel: +1-646-213-1915 (NY office) Email: crocker.coulson@ccgir.com |
| Next Earnings Date: | March 12, 2012 |
| Profit Margin (ttm) | 12.80% |
| Operating Margin(ttm): | 17.18% |
| Return On Assets(ttm): | 7.10% |
| Return On Equity(ttm): | 8.94% |
| Qtrly Revenue Growth (yoy): | -26.60% |
| Operating Cash Flow(ttm): | $19.26M |
| Levered Free Cash Flow(ttm): | $-50.22B |
CSKI closing price for Monday, January 23, 2012 was $1.49, down -0.07, on volume of 90,566.
CSKI is trading 24.23% above its 50 day moving average and -25.31% below its 200 day moving average.
CSKI is -74.79% below its 52-week high of $5.91 and 67.42% above its 52-week low of $0.89.
CSKI‘s PE ratio is 1.66 and its market cap is $25.24M.
China Sky One Medical, Inc.’s Corporate Governance Quotient (CGQ®) as of July 1, 2011 is better than 45.2% of CGQ Universe companies and 50% of Household and Personal Products companies.
Check the following to better Understand Corporate Governance Quotient:
http://help.yahoo.com/l/us/yahoo/finance/news_and_opinion/fitacgq.html
It’s been a good couple of days before the Chinese New Year for China Sky One Medical but a rough year all in all with revenue and growth dropping dramatically from previous years and quarters. It will be interesting to see what CSKI has to report in March when they file their Q4 and 2011 Earnings but it is unlikely that any drastic changes will occur to improve this company’s loss of market share.
About AimHighProfits.com
AimHighProfits.com strives to provide you with the hottest stock alerts in the market in Real-Time. We focus on stocks that trade for $5 per share or less, some as little as a few pennies with upside potential. Our goal is committed to producing and publishing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions and to inform you of the best stocks in the market before they move. Our focus is primarily on OTC stocks in the stock market today which have traditionally been ignored by Wall Street.
We have particular expertise with internet stocks, gold stocks, renewable energy stocks, biotech stocks, oil stocks and green energy stocks. There are many hot penny stock opportunities present in the OTC market every day and we seek to exploit these hot stock gains for our members before the average daytrader is made aware of them.
Aim High Profits Disclaimer
This is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.
AimHighProfits.com is a wholly-owned subsidiary of Kelevra Media Innovation.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
For a complete explanation, please visit our disclaimer page.
ShareJAN
